International Stem Cell Corporation
International Stem Cell Corporation financial statements
International Stem Cell Corporation's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 9.1M | 10-K |
| Net income | −USD 418K | 10-K |
| Cash and equivalents | USD 793K | 10-Q |
International Stem Cell Corporation financials on 6ix · International Stem Cell Corporation on 6ix